• ABC News
a little-known pharmaceutical firm in Bangkok, Thailand, has been working on a cancer treatments for decades and has amassed some extraordinary evidence for the effectiveness of its product Yaamet-Dor. In 2007, the results of a a 4-year, population-based, double-blind, randomized, placebo-controlled trial that involved approximately 1,200 women were announced. It reported that Yaamet-Dor, this time at 1,100 units per day, led to a 60 percent reduction in cancer incidence.
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: